| Literature DB >> 32731377 |
Marta Gambucci1, Elena Cambiotti1, Paola Sassi1, Loredana Latterini1.
Abstract
Surface-enhanced Raman scattering (SERS) is a widely used technique for drug detection due to high sensitivity and molecular specificity. The applicability and selectivity of SERS in the detection of specific drug molecules can be improved by gathering information on the specific interactions occurring between the molecule and the metal surface. In this work, multilayer gold-silver bimetallic nanorods (Au@Ag@AuNRs) have been prepared and used as platforms for SERS detection of specific drugs (namely promethazine, piroxicam, furosemide and diclofenac). The analysis of SERS spectra provided accurate information on the molecular location upon binding and gave some insight into molecule-surface interactions and selectivity in drug detection through SERS.Entities:
Keywords: SERS; bi-metallic colloids; chemical enhancement; drug detection; gold-silver nanostructures
Year: 2020 PMID: 32731377 PMCID: PMC7436262 DOI: 10.3390/molecules25153405
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Morphological and spectroscopic characterization of AuNRs, Au@AgNRs and Au@Ag@AuNRs: (a) TEM image of AuNRs (scale bar 100 nm—Inset: size distribution); (b) TEM image of Au@AgNRs (scale bar 100 nm—Inset: size distribution); (c) TEM image of Au@Ag@AuNRs (scale bar 100 nm); (d) extinction spectra of AuNRs (black line), Au@AgNRs (red line) and Au@Ag@AuNRs (green line).
Average lengths, widths and aspect ratios obtained from TEM analysis of AuNRs, Au@AgNRs and Au@Ag@AuNRs.
| Sample | Length (nm) | Width (nm) | Aspect Ratio | Δlenght (nm) |
|---|---|---|---|---|
| AuNRs | 43.5 (σ = 6.4) | 22.2 (σ = 4.7) | 2.00 (σ = 0.30) | --- |
| Au@AgNRs | 51.2 (σ = 4.9) | 23.3 (σ = 4.0) | 2.22 (σ = 0.48) | 7.7 |
| Au@Ag@AuNRs | ≈55 | ≈42 | ≈1.3 | ≈2.8 |
Figure 2Raman spectra of 10−5 M Rhodamine 6G (Rh6G): (a) Raman spectra in aqueous solution (black line) and in the presence of AuNRs (red line), Au@AgNRs (green line) and Au@Ag@AuNRs (blue line); (b) magnifications of Raman peaks at 1510 cm−1 (spectra have been translated for a better comparison). Rh6G structure is reported as inset in graph (a).
Analytical enhancement factors (calculated based on Raman peak at 1510 cm−1) for Rh6G in the presence of AuNRs, Au@AgNRs and Au@Ag@AuNRs.
| Sample | AEF |
|---|---|
| Rh6G | --- |
| Rh6G + AuNRs | 18 ± 2 |
| Rh6G + Au@AgNRs | 4.9 ± 0.5 |
| Rh6G + Au@Ag@AuNRs | 3650 ± 370 |
Figure 3SERS enhancement of selected drug active ingredients in the presence of Au@Ag@AuNRs: (a) promethazine (10−3 M in aqueous solution); (b) piroxicam (10−3 M in ethanol solution); (c) furosemide (10−2 M in ethanol solution); (d) diclofenac (10−3 M in aqueous solution). Molecular structures of the active ingredients are reported as insets in the respective graphs.
Raman shift and intensity of reference signals for promethazine, piroxicam, furosemide and diclofenac in aqueous solution and in the presence of Au@Ag@AuNRs.
| Sample | Raman Shift (cm−1) | Raman Intensity of Reference Signal |
|---|---|---|
| Promethazine | 1389 | 55 |
| + Au@Ag@AuNRs | 3170 | |
| Piroxicam | 786 | 32 |
| + Au@Ag@AuNRs | 441 | |
| Furosemide | 786 | 294 |
| + Au@Ag@AuNRs | 416 | |
| Diclofenac | [Not detectable] | [Not detectable] |
| + Au@Ag@AuNRs | [Not detectable] |
Figure 4SERS detection limit for promethazine in the presence of Au@Ag@AuNRs: (a) Raman spectra of promethazine at different concentrations; (b) magnification of promethazine Raman signal at 1389 cm−1.